Loading...

Abbvie Inc (NYSE:ABBV)

151.79 USD -1.35 USD ( -0.88% )
Watchlist Manager
Abbvie Inc Logo
Abbvie Inc
NYSE:ABBV
Watchlist

EV/FCFF
Enterprise Value to FCFF

The Enterprise Value to Free Cash Flow To Firm (EV/FCFF) ratio is a valuation multiple that compares the value of a company, debt included, to the amount of free cash flow available for all stakeholders. This metric is very similar to the EV/OCF but is considered a more exact measure, owing to the fact that it uses free cash flow, which subtracts capital expenditures (CapEx) from a company's operating cash flow.

EV/FCFF
=
Enterprise Value
/
FCFF
Current EV/FCFF
ABBV
14.7
Median EV/FCFF
ABBV
12.7
Industry EV/FCFF
Biotechnology
2.3

EV/FCFF History

Statistics
Enterprise Value to FCFF

1 Year 3 Years 5 Years
Average 13.4 12.7 13.4
Median 13.4 13.2 13.7
Min 11.5 8.7 8.7
Max 15.5 16.7 18.6

History Chart
Enterprise Value to FCFF

EV/FCFF Forward Multiples

Forward EV/FCFF multiple is a version of the EV/FCFF ratio that uses forecasted free cash flow to firm for the EV/FCFF calculation. 1-Year, 2-Years, and 3-Years forwards use free cash flow to firm forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/FCFF
N/A
2-Years Forward
EV/FCFF
N/A
3-Years Forward
EV/FCFF
N/A

EV/FCFF Across Competitors

ABBV Competitors
Abbvie Inc Competitors

Country Company Market Cap EV/FCFF
US
Abbvie Inc
NYSE:ABBV
268B USD 14.7
US
Amgen Inc
NASDAQ:AMGN
130B USD 19
AU
CSL Ltd
ASX:CSL
131B AUD 79.6
US
Gilead Sciences Inc
NASDAQ:GILD
78.1B USD 9.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
70.6B USD 25.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
65.9B USD 7.8

Relative Valuation Report

View full relative valuation report for Abbvie Inc, which takes into account all ABBV`s valuation multiples.

See Also

Similar Stocks